Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38:1–211.
Huang TC, Lai TH; Treatment Guideline Subcommittee of Taiwan Headache Society. Medical treatment guidelines for preventive treatment of migraine. Acta Neurol Taiwan 2017;26:33–53.
Hsu YC, Lin KC; Treatment Guideline Subcommittee of Taiwan Headache Society. Medical treatment guidelines for acute migraine attacks. Acta Neurol Taiwan 2017;26:78–96.
Ailani J, Burch RC, Robbins MS; Board of Directors of the American Headache Society. The American Headache Society consensus statement: update on integrating new migraine treatments into clinical practice. Headache 2021;61:1021–1039.
Charles AC, et al. Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: an American Headache Society position statement update. Headache 2024;64:333–341. doi:10.1111/head.14692
Sacco S, et al. European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update. J Headache Pain 2022;23:67. doi:10.1186/s10194-022-01431-x
Do TP, et al. Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list. Neurology 2019;92:134–144.